Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05082610 |
|---|---|
| Brief Title: | A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab |
| First Submitted : | September 21, 2021 |
| First Submitted that Met QC Criteria : | October 14, 2021 |
| First Posted : | October 19, 2021 |
| Last Update Submitted that Met QC Criteria : | April 27, 2023 |
| Last Update Posted : | May 1, 2023 |